Leukemia inhibitory factor induces an antiapoptotic response in oligodendrocytes through Akt-phosphorylation and up-regulation of 14-3-3

Proteomics

Volumn 8, Issue 6, 2008, Pages 1237-1247

  Slaets, Helena ^a   Dumont, Debora ^a   Vanderlocht, Joris ^a   Noben, Jean Paul ^a   Leprince, Pierre ^b   Robben, Johan ^a   Hendriks, Jerome ^a   Stinissen, Piet ^a   Hellings, Niels ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

DIGE; Leukemia inhibitory factor; Multiple sclerosis; Oligodendrocytes

Indexed keywords

GAMMA INTERFERON; JANUS KINASE; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN 14 3 3; PROTEIN BCL 2; PROTEIN KINASE B; STAT3 PROTEIN; STAUROSPORINE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; OLIGODENDROGLIA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; UPREGULATION;

14-3-3 PROTEINS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEUKEMIA INHIBITORY FACTOR; OLIGODENDROGLIA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TANDEM MASS SPECTROMETRY; TRANSCRIPTION, GENETIC; UP-REGULATION;

ANIMALIA; RATTUS;

EID: 41549154629     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700641     Document Type: Article

References (58)

1. Buntinx, M., Moreels, M., Vandenabeele, F., Lambrichts, I. et al., Cytokine-induced cell death in human Oligodendroglial cell lines: I. Synergistic effects of IFN-gamma and TNF-alpha on apoptosis. J. Neurosci. Res. 2004, 76, 834-845.
2. Vanderlocht, J., Hellings, N., Hendriks, J. J., Vandenabeele, F. et al., Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-alpha-induced oligodendrocyte apoptosis. J. Neurosci. Res. 2006, 83, 763-774.
3. Zhang, X., Haaf, M., Todorich, B., Grosstephan, E. et al., Cytokine toxicity to oligodendrocyte precursors is mediated by iron. Glia 2005, 52, 199-208.
4. Imitola, J., Chitnis, T., Khoury, S. J., Cytokines in multiple sclerosis: From bench to bedside. Pharmacol. Ther. 2005, 106, 163-177.
5. Hellings, N., Gelin, G., Medaer, R., Bruckers, L. et al., Long-itudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis: Association with clinical and MRI activity. J. Neuroimmunol. 2002, 126, 143-160.
6. Karadottir, R., Attwell, D., Neurotransmitter receptors in the life and death of oligodendrocytes. Neuroscience 2007, 145, 1426-1438.
7. Rus, H., Cudrici, C., Niculescu, F., Shin, M. L., Complement activation in autoimmune demyelination: Dual role in neuroinflammation and neuroprotection. J. Neuroimmunol. 2006, 180, 9-16.
8. Buntinx, M., Stinissen, P., Steels, P., Ameloot, M. et al., Immune-mediated oligodendrocyte injury in multiple sclerosis: Molecular mechanisms and therapeutic interventions. Crit Rev. Immunol. 2002, 22, 391-424.
9. Smith, K. J., Kapoor, R., Felts, P. A., Demyelination: The role of reactive oxygen and nitrogen species. Brain Pathol. 1999, 9, 69-92.
10. Mayer, M., Bhakoo, K., Noble, M., Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 1994, 120, 143-153.
11. Azari, M. F., Profyris, C., Karnezis, T., Bernard, C. C. et al., Leukemia inhibitory factor arrests oligodendrocyte death and demyelination in spinal cord injury. J. Neuropathol. Exp. Neurol. 2006, 65, 914-929.
12. Butzkueven, H., Emery, B., Cipriani, T., Marriott, M. P. et al., Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss. Glia 2006, 53, 696-703.
13. Vanderlocht, J., Hendriks, J. J., Venken, K., Stinissen, P. et al., Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls. J. Neuroimmunol. 2006, 177, 189-200.
14. Butzkueven, H., Zhang, J. G., Soilu-Hanninen, M., Hochrein, H. et al., LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat. Med. 2002, 8, 613-619.
15. Linker, R. A., Maurer, M., Gaupp, S., Martini, R. et al., CNTF is a major protective factor in demyelinating CNS disease: A neurotrophic cytokine as modulator in neuroinflammation. Nat. Med. 2002, 8, 620-624.
16. Heinrich, P. C., Behrmann, I., Haan, S., Hermanns, H. M. et al., Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 2003, 374, 1-20.
17. Magni, P., Dozio, E., Ruscica, M., Watanobe, H. et al., Leukemia inhibitory factor induces the chemomigration of immortalized gonadotropin-releasing hormone neurons through the independent activation of the Janus kinase/signal transducer and activator of transcription 3, mitogen-activated protein kinase/extracellularly regulated kinase 1/2, and phosphatidylinositol 3-kinase/Akt signaling pathways. Mol. Endocrinol. 2007, 21, 1163-1174.
18. Auernhammer, C. J., Chesnokova, V., Bousquet, C., Melmed, S., Pituitary corticotropin SOCS-3: Novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion. Mol. Endocrinol. 1998, 12, 954-961.
19. Duval, D., Reinhardt, B., Kedinger, C., Boeuf, H., Role of suppressors of cytokine signaling (Socs) in leukemia inhibitory factor (LIF) -dependent embryonic stem cell survival. FASEB J. 2000, 14, 1577-1584.
20. Karlsen, A. E., Ronn, S. G., Lindberg, K., Johannesen, J. et al., Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma-mediated toxicity. Proc. Natl. Acad. Sci. USA 2001, 98, 12191-12196.
21. Kimura, A., Naka, T., Nagata, S., Kawase, I. et al., SOCS-1 suppresses TNF-alpha-induced apoptosis through the regulation of Jak activation. Int. Immunol. 2004, 16, 991-999.
22. Battle, T. E., Frank, D. A., The role of STATs in apoptosis. Curr. Mol. Med. 2002, 2, 381-392.
23. Grad, J. M., Zeng, X. R., Boise, L. H., Regulation of Bcl-xL: A little bit of this and a little bit of STAT. Curr. Opin. Oncol. 2000, 12, 543-549.
24. Nielsen, M., Kaestel, C. G., Eriksen, K. W., Woetmann, A. et al., Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells. Leukemia 1999, 13, 735-738.
25. Stephanou, A., Brar, B. K., Knight, R. A., Latchman, D. S., Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death. Differ. 2000, 7, 329-330.
26. Mhawech, P., 14-3-3 proteins - An update. Cell Res. 2005, 15, 228-236.
27. Buntinx, M., Gielen, E., Van Hummelen, P., Raus, J. et al., Cytokine-induced cell death in human oligodendroglial cell lines. II: Alterations in gene expression induced by interferon-gamma and tumor necrosis factor-alpha. J. Neurosci. Res. 2004, 76, 846-861.
28. Dumont, D., Noben, J. P., Moreels, M., Vanderlocht, J. et al., Characterization of mature rat oligodendrocytes: A proteomic approach. J. Neurochem. 2007,
29. Douette, P., Navet, R., Gerkens, P., de Pauw, E. et al., Steatosis-induced proteomic changes in liver mitochondria evidenced by two-dimensional differential in-gel electrophoresis. J. Proteome Res. 2005, 4, 2024-2031.
30. Dumont, D., Noben, J. P., Raus, J., Stinissen, P. et al., Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients. Proteomics 2004, 4, 2117-2124.
31. Shevchenko, A., Wilm, M., Vorm, O., Mann, M., Mass spectrometry sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68, 850-858.
32. Meiring, H. D., van der Heeft, E., ten Hove, G. J., De Jong, A. P. J. M., Nanoscale LC-MS(n): Technical design and applications to peptide and protein analysis. J. Sep. Sci. 2002, 25, 557-568.
33. Benjamins, J. A., Nedelkoska, L., George, E. B., Protection of mature oligodendrocytes by inhibitors of caspases and calpains. Neurochem. Res. 2003, 28, 143-152.
34. Mronga, T., Stahnke, T., Goldbaum, O., Richter-Landsberg, C., Mitochondrial pathway is involved in hydrogen-peroxide-induced apoptotic cell death of oligodendrocytes. Glia 2004, 46, 446-455.
35. Emery, B., Butzkueven, H., Snell, C., Binder, M. et al., Oligodendrocytes exhibit selective expression of suppressor of cytokine signaling genes and signal transducer and activator of transcription 1 independent inhibition of interferon-gamma-induced toxicity in response to leukemia inhibitory factor. Neuroscience 2006, 137, 463-472.
36. Lee, N., Neitzel, K. L., Devlin, B. K., MacLennan, A. J., STAT3 phosphorylation in injured axons before sensory and motor neuron nuclei: Potential role for STAT3 as a retrograde signaling transcription factor. J. Comp. Neurol. 2004, 474, 535-545.
37. Schweizer, U., Gunnersen, J., Karch, C., Wiese, S. et al., Conditional gene ablation of Stat3 reveals differential signaling requirements for survival of motoneurons during development and after nerve injury in the adult. J. Cell Biol. 2002, 156, 287-297.
38. Maier, K., Rau, C. R., Storch, M. K., Sattler, M. B. et al., Ciliary neurotrophic factor protects retinal ganglion cells from secondary cell death during acute autoimmune optic neuritis in rats. Brain Pathol. 2004, 14, 378-387.
39. Bowman, T., Garcia, R., Turkson, J., Jove, R., STATs in oncogenesis. Oncogene 2000, 19, 2474-2488.
40. Barres, B. A., Schmid, R., Sendnter, M., Raff, M. C., Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993, 118, 283-295.
41. Emery, B., Cate, H. S., Marriott, M., Merson, T. et al., Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination. Proc. Natl. Acad. Sci. USA 2006, 103, 7859-7864.
42. Negoro, S., Oh, H., Tone, E., Kunisada, K. et al., Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction. Circulation 2001, 103, 555-561.
43. Hobom, M., Storch, M. K., Weissen, R., Maier, K. et al., Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis. Brain Pathol. 2004, 14, 148-157.
44. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z. et al., Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96, 857-868.
45. Datta, S. R., Dudek, H., Tao, X., Masters, S. et al., Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91, 231-241.
46. Masters, S. C., Subramanian, R. R., Truong, A., Yang, H. et al., Survival-promoting functions of 14-3-3 proteins. Biochem. Soc. Trans. 2002, 30, 360-365.
47. Rosenquist, M., 14-3-3 proteins in apoptosis. Braz. J. Med. Biol. Res. 2003, 36, 403-408.
48. Berg, D., Holzmann, C., Riess, O., 14-3-3 proteins in the nervous system. Nat. Rev. Neurosci. 2003, 4, 752-762.
49. Sattler, M. B., Merkler, D., Maier, K., Stadelmann, C. et al., Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell Death. Differ. 2004, 11, S181-S192.
50. Chong, Z. Z., Maiese, K., Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrity. Br. J. Pharmacol. 2007, 150, 839-850.
51. Subramanian, R. R., Zhang, H., Wang, H., Ichijo, H. et al., Interaction of apoptosis signal-regulating kinase 1 with isoforms of 14-3-3 proteins. Exp. Cell Res. 2004, 294, 581-591.
52. Fanger, G. R., Widmann, C., Porter, A. C., Sather, S. et al., 14-3-3 proteins interact with specific MEK kinases. J. Biol. Chem. 1998, 273, 3476-3483.
53. Adam, L. P., Hathaway, D. R., Identification of mitogen-activated protein kinase phosphorylation sequences in mammalian h-Caldesmon. FEBS Lett. 1993, 322, 56-60.
54. Suh, K. S., Mutoh, M., Gerdes, M., Crutchley, J. M. et al., Antisense suppression of the chloride intracellular channel family induces apoptosis, enhances tumor necrosis factor {alpha}-induced apoptosis, and inhibits tumor growth. Cancer Res. 2005, 65, 562-571.
55. Han, S., Zhang, K. H., Lu, P. H., Xu, X. M., Effects of annexins II and V on survival of neurons and astrocytes in vitro. Acta Pharmacol. Sin. 2004, 25, 602-610.
56. Reutelingsperger, C. P., van Heerde, W. L., Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis. Cell Mol. Life Sci. 1997, 53, 527-532.
57. MacKeigan, J. P., Clements, C. M., Lieh, J. D., Pope, R. M. et al., Proteomic profiling drug-induced apoptosis in nonsmall cell lung carcinoma: Identification of RS/DJ-1 and RhoG-DIalpha. Cancer Res. 2003, 63, 6928-6934.
58. Zhang, B., Zhang, Y., Dagher, M. C., Shacter, E., Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis. Cancer Res. 2005, 65, 6054-6062.